Candida albicans persisters constitute a small subpopulation of biofilm cells and play a major role in recalcitrant chronic candidiasis; however, the mechanism underlying persister formation remains unclear. Persisters are often described as dormant, multidrug-tolerant, nongrowing cells. Persister cells are difficult to isolate and study not only due to their low levels in C. albicans biofilms but also due to their transient, reversible phenotype. In this study, we tried to induce persister formation by inducing C. albicans cells into a dormant state. C. albicans cells were pretreated with 5-fluorocytosine (planktonic cells, 0.8 g ml ؊1 ; biofilm cells, 1 g ml ؊1 ) for 6 h at 37°C, which inhibits nucleic acid and protein synthesis. Biofilms and planktonic cultures of eight C. albicans strains were surveyed for persisters after amphotericin B treatment (100 g ml ؊1 for 24 h) and CFU assay. None of the planktonic cultures, with or without 5-fluorocytosine pretreatment, contained persisters. Persister cells were found in biofilms of all tested C. albicans strains, representing approximately 0.01 to 1.93% of the total population. However, the persister levels were not significantly increased in C. albicans biofilms pretreated with 5-fluorocytosine. These results suggest that inhibition of nucleic acid synthesis did not seem to increase the formation of amphotericin B-tolerant persisters in C. albicans biofilms.
C
andida albicans is the most prevalent opportunistic pathogen in humans, causing endogenous infections ranging from superficial to seriously deep-seated mycoses (1, 2) . Candida species are also the most common fungal pathogens causing hospitalacquired infections (3) (4) (5) . While increasing rates of candidemia caused by non-albicans Candida species have been reported worldwide, C. albicans is still the most common pathogen responsible for candidemia (3, (6) (7) (8) . Although candidemia rates differ between countries, recent epidemiological data from the United States, Europe, and Latin America show an overall increase in the incidence of candidemia in the last decade (5, (9) (10) (11) (12) . Most Candida infections involve biofilm formation and often pose a poor prognosis due to drug tolerance; these infections are associated with a high rate of mortality, approaching 40 to 70% (1, 2, (13) (14) (15) (16) (17) (18) (19) . Biofilm-related drug tolerance may be attributed to high cell density and low growth rates within the biofilm, the presence of exopolymer matrix, and upregulation of drug efflux pumps and stress responses (2, (20) (21) (22) (23) (24) (25) . Indeed, increasing evidence indicates that the mechanism of biofilm-related drug tolerance is multifactorial (23) (24) (25) . Within the C. albicans biofilm, a small population of persister cells that can withstand lethal antifungal treatment is believed to be responsible for the poor prognosis (26, 27) . However, the mechanism of C. albicans persister formation remains unknown, and the low levels of persisters and their transience make them difficult to isolate. The inability of an antifungal agent to eradicate persisters is thought to result from the quiescent physiological state because antifungal agents need a physiologically/metabolically active target to function (2, 27, 28) . Persisters may be the main culprit in the recurring symptoms of fungal infections because the persisters can produce a new biofilm with a similar persister level and an equivalent antifungal susceptibility (25, (29) (30) (31) .
C. albicans persisters have so far been detected only in biofilms, comprising only 0.01% to 2% of mature biofilms (26, 29, (32) (33) (34) .
Persisters exhibit a nonhereditary, multidrug tolerance to antifungals and are described as dormant, nondividing phenotypic variants (27-30, 32, 35) . The dormant cells are characterized by quiescent metabolisms, such as nucleic acid synthesis and protein synthesis (26, 27, 36) . Kwan reported recently that the pretreatment of Escherichia coli with antibiotics that can halt transcription, translation, or ATP synthesis dramatically increased persistence (37) . The main mechanisms underlying persister formation seem to be inhibition of anabolism and dissipation of the proton motive force (36) . Therefore, we speculated that induced dormancy could increase the formation of antifungal-tolerant persisters. 5-Fluorocytosine (5-FC) is a nucleoside analog with antifungal activities that inhibits nucleic acid and protein synthesis. In this study, we attempted to induce C. albicans cells into dormancy with 5-FC to investigate whether inhibition of nucleic acid synthesis could increase C. albicans persister formation.
MATERIALS AND METHODS
Strains and growth conditions. Eight C. albicans strains were tested in this study (Table 1) . C. albicans 3153A (29) and YEM30 (38, 39) are wildtype strains. C. albicans DSY653 and DSY654 (39, 40) are CDR1 and CDR2 knockout strains donated by K. Lewis from Northeastern University, Boston, MA. C. albicans CJN308 and CJN459 (41) are biofilm-deficient strains. C. albicans 11E and 23A are clinical isolates, whose origins have been described previously (26) . C. albicans 11E is a high-persister clinical isolate, while 23A is a low-persister clinical isolate (26) . Stock cultures of C. albicans strains were routinely grown in YPD (1% yeast extract, 2% peptone, 2% glucose) solid medium containing 1.5% agar and incubated at 37°C for 24 to 48 h. Yeast inocula were prepared by transfer of a single colony into YPD medium and overnight incubation at 37°C in an incubator shaker at about 100 rpm. Cells were harvested by centrifugation at 6,000 ϫ g for 3 min and washed twice in sterile phosphatebuffered saline (PBS [pH 7.2 to 7.4]). Then the cells were resuspended in RPMI 1640 medium (Gibco) with L-glutamine, buffered to pH 7.0 with 0.165 M morpholinepropanesulfonic acid (MOPS [Sigma-Aldrich]), and adjusted to the desired density after being counted with a hemocytometer.
MIC assay. CLSI M27-A3 microdilution methodology was used to test in vitro susceptibility to amphotericin B (Amresco) and 5-FC (SigmaAldrich) (42) . The inoculated cultures were incubated for 24 h at 37°C, and the MIC 90 was determined by observing growth inhibition, as measured by turbidity. Experiments were performed in quadruplicate and repeated with at least four independent cultures.
Growth and 5-FC pretreatment of planktonic cells. Planktonic cultures of C. albicans were prepared according to the methods described by Al-Dhaheri and Douglas (32) . Briefly, C. albicans cells were harvested by centrifugation, washed twice in sterile PBS, and resuspended in RPMI 1640 medium plus MOPS at a density of 1.0 ϫ 10 7 cells ml Ϫ1 . The planktonic cells were either used to determine the persister levels or pretreated with 5-FC and then used to determine the persister levels. Pretreated planktonic cells were exposed to 5-FC (0.8 g ml Ϫ1 ) for 6 h at 37°C. The pretreatment concentration and duration were optimized for maximum survivability (approximately 95% to 100%; P Ͼ 0.05).
Growth and 5-FC pretreatment of biofilms. C. albicans biofilm formation was induced as described by Ramage et al. (29, 43) . Briefly, C. albicans cells were harvested from an overnight culture by centrifugation, washed twice in sterile PBS, and resuspended in RPMI 1640 medium plus MOPS at a density of 1.0 ϫ 10 6 cells ml Ϫ1 . One hundred microliters of the suspension was dispensed into the wells of 96-well microtiter plates, and the plates were incubated for 24 h at 37°C at approximately 100 rpm. The biofilms either were used to determine the persister levels or were first pretreated with 5-FC, after which the persister levels were determined. The pretreated biofilm cells were exposed to 5-FC (1 g ml Ϫ1 ) for 6 h at 37°C. The pretreatment concentration and duration were optimized for maximum survivability (approximately 95% to 100%; P Ͼ 0.05).
C. albicans cells were pretreated by exposure to 5-FC throughout biofilm formation. Briefly, C. albicans cells were harvested, washed, and then resuspended in RPMI 1640 medium containing 5-FC (0.55 g ml Ϫ1 ) at a density of 1.0 ϫ 10 6 cells ml Ϫ1 . One hundred microliters of the suspension was dispensed into the wells of 96-well microtiter plates, and the plates were incubated for 24 h at 37°C. The pretreatment concentration of 5-FC was optimized for maximum survivability (approximately 95% to 100%; P Ͼ 0.05).
Persister cell determination. Amphotericin B was dissolved in RPMI 1640 medium plus MOPS at 100 g ml Ϫ1 , which exceeded 10ϫ the MIC to minimize survival of potential spontaneous resistant mutants (26, 29, 32, 33) . The planktonic cells were harvested, washed twice in PBS, aliquoted into wells of microtiter plates at 100 l per well, and treated for 24 h with amphotericin B (100 g ml Ϫ1 ) in RPMI 1640 medium plus MOPS. The biofilms were washed twice in PBS and treated with amphotericin B (100 g ml Ϫ1 ) for 24 h. The number of persister cells was determined based on an assessment of cell viability after amphotericin B treatment, by harvesting and serially diluting C. albicans cells in sterile PBS, plating 5-l drops on YPD solid medium, and counting colonies (26, 29, (32) (33) (34) . The percentage of persisters was determined by comparing the number of persisters with the total number of viable cells in an untreated culture.
LIVE/DEAD cell staining and confocal laser scanning microscopy. The LIVE/DEAD FungaLight yeast viability kit (Invitrogen), which contains SYTO9 and propidium iodide, was used to distinguish between live and dead yeast cells. When used alone, the SYTO9 green fluorescent nucleic acid stain generally labels all of the yeast cells in a population, while propidium iodide penetrates only yeast cells with damaged membranes, causing a reduction in the SYTO9 stain fluorescence when both dyes are present. As a result, live cells stain fluorescent green, whereas dead cells stain fluorescent red. Biofilms and planktonic cells of the C. albicans 3153A strain were washed twice with sterile Tris-HCl buffer (pH 6.8) before and after amphotericin B treatment. Then the samples were treated with 100 l Tris-HCl buffer containing 1‰ SYTO9 and 1‰ propidium iodide and incubated for 15 to 30 min in the dark at 37°C. After incubation with the dyes, stained samples were viewed with a Zeiss LSM780 confocal laser scanning microscope (CLSM).
RESULTS AND DISCUSSION
C. albicans persisters were first reported to occur following treatment with amphotericin B or chlorhexidine at a high concentration (29) . Dose-dependent killing has been the only effective and straightforward method for identification and isolation of C. albicans persisters (26, 29, (32) (33) (34) 37) . In the present study, we used the same protocol with amphotericin B to identify persister levels. Amphotericin B is the most effective antifungal agent and can kill fungal cells in all phases of growth, making it the optimum choice to isolate persisters, regardless of whether 5-FC pretreatment inhibits replication (26, 29, 32, 33) .
Presence of persisters in C. albicans biofilms and planktonic cultures. Biofilms and planktonic cells of eight C. albicans strains were surveyed for the presence of persisters after amphotericin B treatment. C. albicans persisters were detected in biofilms of all tested C. albicans strains (Fig. 1) , while none of the planktonic cultures contained persisters. CLSM micrographs of LIVE/DEAD cell staining (C. albicans strain 3153A) also showed that after exposure to amphotericin B, the planktonic cells were effectively killed, without detectable survivors stained fluorescent green ( Fig. 2A and C) , while biofilms contained a small number of survivors ( Fig. 2E and G) . The CLSM analysis provided further evi- dence that C. albicans persister cells were detected only in biofilms. For all tested C. albicans strains, the persister percentage was approximately 0.01 to 1.93% of the total population of mature biofilms. In agreement with previous data (26, 29, (32) (33) (34) , our results further confirm that C. albicans persister cells seem to be present only in biofilms and are absent in planktonic cultures. 5-FC pretreatment makes little difference to C. albicans persister formation. 5-FC is a nucleoside analog with antifungal activities that inhibits nucleic acid and protein synthesis. The antifungal activity of 5-FC is a consequence of two metabolites, 5-fluorodeoxyuridine monophosphate and 5-fluorouridine triphosphate, which result in inhibition of the synthesis of nucleic acid and protein (44) (45) (46) (47) (48) . Currently, 5-FC is the only antifungal agent in use that can inhibit replication, transcription, and translation. Recently researchers found that pretreatment of Escherichia coli with some antibiotics that can halt transcription, translation, or ATP synthesis can increase persistence dramatically (37) . Hence, we speculated that maybe 5-FC could be used to induce C. albicans cells into a dormant state to increase persister formation by inhibiting nucleic acid and protein synthesis.
In the present study, we tested whether 5-FC pretreatment of eight C. albicans strains would increase persister formation. C. albicans cells were exposed to 5-FC (planktonic cells, 0.8 g ml Ϫ1 ; biofilm cells, 1 g ml Ϫ1 ) for 6 h prior to CFU assay and amphotericin B treatment. Our results showed that the number of C. albicans cells neither increased nor decreased significantly after 5-FC pretreatment (P Ͼ 0.05) (Fig. 1) . CLSM micrographs also showed that there was no significant difference before and after 5-FC pretreatment, without clear indications of the killing of cells ( Fig. 2A, B , E, and F; Fig. 3A and B) . The results indicated that planktonic and biofilm cells of C. albicans appeared to be induced successfully into a dormancy-like state by 5-FC pretreatment. According to the hypothesis that dormancy results in the development of persister cells, C. albicans persisters should be increased significantly in cultures pretreated with 5-FC. However, contrary to our hypothesis, the formation of persisters was not significantly increased in cultures pretreated with 5-FC (P Ͼ 0.05) (Fig. 1, Fig.  2C , D, G, and H, and Fig. 3C and D) .
To provide further evidence that the survivors were "true" persisters, we tested the survivors to see whether they showed the slow loss of viability characteristic of persisters (29) . Hence, we exposed the pretreated and nonpretreated biofilms to amphotericin B for a prolonged period and quantified the survivors at several time points. Our results showed that the survivors exhibited slow, steady cell death for up to 8 h of prolonged amphotericin B treatment (P Ͼ 0.05) (Fig. 4) . Therefore, the persisters detected in the present study are "true" persisters, rather than spontaneous resistant mutants that are able to survive and even grow in the presence of an antifungal agent.
Our results suggest that inhibition of nucleic acid synthesis does not increase C. albicans persister formation. This finding is different from those of earlier studies in bacteria, in which bacterial persisters can be induced by inhibiting transcription or translation (37) . Although dormancy appears to be the main mechanism underlying bacterial persister formation (36, 37) , our results suggest that dormancy has a negligible effect on C. albicans persister formation. Compared with bacterial persisters, the formation of C. albicans persisters is likely to be multifactorial and more complicated.
We also attempted to induce C. albicans cells into dormancy to increase persister formation by exposing C. albicans strains 3153A, 11E, and 23A to 5-FC (0.55 g ml Ϫ1 ) throughout biofilm formation. Our results showed that after incubation for 24 h, C. albicans cells maintained the yeast form without indications of an increase in number, in comparison with that of the initial inocula (Fig. 5A) . In contrast, cells in the nonpretreated biofilms presented as yeast cells, pseudohyphae, and hyphae and formed a dense network of cells of all morphologies (Fig. 2E) . After exposure to amphotericin B (100 g ml Ϫ1 ), the proportion of persister cells increased, but the number of persister cells did not increase significantly in the pretreated biofilms (P Ͼ 0.05) (Fig. 5B) . Given that the number of C. albicans cells did not increase significantly after incubation for 24 h, the increase in the proportion of persisters could be attributed to inhibited growth rather than to an increase in persister formation (Fig. 5) . Although only three C. albicans strains were tested in this part of the experiment, the results once again clearly indicate that inhibition of nucleic acid synthesis does not appear to be the mechanism underlying C. albicans persister formation. The formation of C. albicans persisters seems more complicated than that of bacterial persisters; hence, further study is required.
In clinical practice, combination therapy with amphotericin B and 5-FC may be used to treat candidiasis to achieve antifungal synergy and to prevent the development of fungal resistance (44, 49, 50) . It should be noted that combination therapy using amphotericin B with 5-FC does not eradicate persisters.
The conclusions of this study are limited because only eight C. albicans strains were tested. Although this is a preliminary study, our results suggest that dormancy seems not to be the mechanism of C. albicans persister formation and that in comparison to bac- terial persisters, the formation of C. albicans persisters appears to be multifactorial and more complicated. However, since dormancy is an important feature of persisters, it is premature to rule out dormancy as the cause of fungal persisters. Additional studies are needed to investigate the mechanism of fungal persister formation.
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